• Banner

  • Reduced price
Interferons: Characterization, Mechanism of Action & Clinical Applications

Interferons: Characterization, Mechanism of Action & Clinical Applications

9781620812983
900,84 zł
810,75 zł Save 90,09 zł Tax included
Lowest price within 30 days before promotion: 810,75 zł
Quantity
Available in 4-6 weeks

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DHL, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Description
Interferons are cytokines that are very important in regulating both innate and adaptive immune response. Of the two different types of interferons, Type I interferons are potent mediators of the innate immune response against viruses and cancer. Type II interferons, mainly IFN-y enhances T cell polarisation in the lymph nodes that result in their expansion. This book discusses the characterisation, mechanisms of action and clinical applications of interferons. Topics include interferon-gamma, oligodendrocyte injury and inflammatory demyelination; the role of IFN-y in oesophageal squamous cell carcinoma; interferons in multiple sclerosis; the effect of interferons on NK cell activity in HIV infection and tumour cell development; and understanding the mechanisms of interaction between serine proteases, serine protease receptors and interferons.
Product Details
73769
9781620812983
9781620812983

Data sheet

Rok wydania
2012
Numer wydania
1
Oprawa
twarda
Liczba stron
172
Wymiary (mm)
180.00 x 260.00
Waga (g)
548
  • Preface; Interferon Regulatory Factors in Immune Cell Development & Host Response to Infections; Interferon-Gamma, Oligodendrocyte Injury & Inflammatory Demyelination; Interferons & their Effect on NK Cells Activity in HIV Infection & Tumour Cells Development; Interferons, Serine Proteases & Protease-Activated Receptors:: Enemies or Partners?; The Roles of IFN-? in Esophageal Squamous Cell Carcinoma; Interferons in Multiple Sclerosis:: Clinical Applications & Possible Mechanisms of Actions; Dynamics of Lymphocyte Subpopulations in Patients with Chronic Hepatitis C Virus Infection During Pegylated Interferon-Alpha2a & Ribavirin Treatment.
Comments (0)